{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T05:12:39Z","timestamp":1773810759518,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005687","name":"Goethe-Universit\u00e4t Frankfurt am Main","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005687","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.yebeh.2022.108988","type":"journal-article","created":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T11:49:47Z","timestamp":1669031387000},"page":"108988","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Supply problems of antiseizure medication are common among epilepsy patients in Germany"],"prefix":"10.1016","volume":"138","author":[{"given":"Catrin","family":"Mann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarita","family":"Maltseva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"von Podewils","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Knake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stjepana","family":"Kovac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Rosenow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Strzelczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.yebeh.2022.108988_b0005","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: a practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108988_b0010","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S1474-4422(17)30299-5","article-title":"Global regional, and national burden of neurological disorders during 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"16","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2022.108988_b0015","series-title":"S1-Leitlinie Erster epileptischer Anfall und Epilepsien im Erwachsenenalter. Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie","author":"Elger","year":"2017"},{"issue":"2","key":"10.1016\/j.yebeh.2022.108988_b0020","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1212\/WNL.0000000000005755","volume":"91","author":"Kanner","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2022.108988_b0025","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1528-1167.2007.01414.x","article-title":"Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population","volume":"49","author":"Davis","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108988_b0030","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.nrl.2017.02.004","article-title":"Unravelling the mysteries of sudden unexpected death in epilepsy","volume":"34","author":"Hampel","year":"2019","journal-title":"Neurologia (Engl Ed)"},{"issue":"5","key":"10.1016\/j.yebeh.2022.108988_b0035","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1212\/WNL.0000000000002791","article-title":"Nonadherence to antiepileptic drugs in Germany: A retrospective, population-based study","volume":"87","author":"Gollwitzer","year":"2016","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.yebeh.2022.108988_b0040","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1111\/epi.17229","article-title":"Trends in resource utilization and cost of illness in patients with active epilepsy in Germany from 2003 to 2020","volume":"63","author":"Willems","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108988_b0045","doi-asserted-by":"crossref","first-page":"108650","DOI":"10.1016\/j.yebeh.2022.108650","article-title":"Gender differences in concerns about planning to have children and child-rearing among patients with epilepsy: A prospective, multicenter study with 477 patients from Germany","volume":"129","author":"Mann","year":"2022","journal-title":"Epilepsy Behav"},{"issue":"4","key":"10.1016\/j.yebeh.2022.108988_b0050","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/epi.17174","article-title":"Multicenter, cross-sectional study of the costs of illness and cost-driving factors in adult patients with epilepsy","volume":"63","author":"Willems","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108988_b0055","doi-asserted-by":"crossref","first-page":"108666","DOI":"10.1016\/j.yebeh.2022.108666","article-title":"Trends in antiseizure medication prescription patterns among all adults, women, and older adults with epilepsy: A German longitudinal analysis from 2008 to 2020","volume":"130","author":"Hochbaum","year":"2022","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108988_b0060","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.seizure.2022.06.004","article-title":"Persistent knowledge gaps between 2005 and 2020 in women with epilepsy: Comparison of multicenter studies from Germany","volume":"100","author":"Mann","year":"2022","journal-title":"Seizure"},{"issue":"9","key":"10.1016\/j.yebeh.2022.108988_b0065","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S1474-4422(12)70153-9","article-title":"Adverse effects of antiepileptic drugs","volume":"11","author":"Perucca","year":"2012","journal-title":"Lancet Neurol"},{"issue":"37","key":"10.1016\/j.yebeh.2022.108988_b0070","doi-asserted-by":"crossref","first-page":"5740","DOI":"10.2174\/1381612823666170809103202","article-title":"Antiepileptic Treatments in Developing Countries","volume":"23","author":"Jost","year":"2018","journal-title":"Curr Pharm Des"},{"issue":"9848","key":"10.1016\/j.yebeh.2022.108988_b0075","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0140-6736(12)61381-6","article-title":"Epilepsy in poor regions of the world","volume":"380","author":"Newton","year":"2012","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.yebeh.2022.108988_b0080","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.braindev.2016.01.005","article-title":"The lack of antiepileptic drugs and worsening of seizures among physically handicapped patients with epilepsy during the Great East Japan Earthquake","volume":"38","author":"Kobayashi","year":"2016","journal-title":"Brain Dev"},{"issue":"6","key":"10.1016\/j.yebeh.2022.108988_b0085","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S1474-4422(20)30035-1","article-title":"30 years of second-generation antiseizure medications: impact and future perspectives","volume":"19","author":"Perucca","year":"2020","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2022.108988_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1684\/epd.2022.1468","article-title":"Recommendations for treatment strategies in people with epilepsy during times of shortage of antiseizure medications","volume":"24","author":"Asadi-Pooya","year":"2022","journal-title":"Epileptic Disord"},{"issue":"5","key":"10.1016\/j.yebeh.2022.108988_b0095","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1528-1167.2010.02520.x","article-title":"Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy","volume":"51","author":"Canevini","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108988_b0100","doi-asserted-by":"crossref","first-page":"108343","DOI":"10.1016\/j.yebeh.2021.108343","article-title":"Patients' knowledge about epilepsy-related risks, morbidity, and mortality: A multicenter cohort study from Germany","volume":"124","author":"Schwab","year":"2021","journal-title":"Epilepsy Behav"},{"issue":"Suppl 9","key":"10.1016\/j.yebeh.2022.108988_b0105","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1528-1167.2007.01392.x","article-title":"An overview of epilepsy and driving","volume":"48","author":"Drazkowski","year":"2007","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.yebeh.2022.108988_b0110","doi-asserted-by":"crossref","first-page":"74","DOI":"10.14581\/jer.18012","article-title":"Validity of the Liverpool Adverse Events Profile as a Screening Tool for Detecting Comorbid Depression or Anxiety Disorder in People with Epilepsy","volume":"8","author":"Kwon","year":"2018","journal-title":"J Epilepsy Res"},{"issue":"5","key":"10.1016\/j.yebeh.2022.108988_b0115","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s40258-019-00487-2","article-title":"General Trends in Prices and Prescription Patterns of Anticonvulsants in Germany between 2000 and 2017: Analysis of National and Cohort-Based Data","volume":"17","author":"Willems","year":"2019","journal-title":"Appl Health Econ Health Policy"},{"key":"10.1016\/j.yebeh.2022.108988_b0120","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1001\/jamaneurol.2017.0497","article-title":"Bioequivalence Between Generic and Branded Lamotrigine in People With Epilepsy: The EQUIGEN Randomized Clinical Trial","volume":"74","author":"Berg","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.yebeh.2022.108988_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.seizure.2017.03.012","article-title":"Brand-to-generic levetiracetam switch in patients with epilepsy in a routine clinical setting","volume":"48","author":"Markoula","year":"2017","journal-title":"Seizure"},{"issue":"7","key":"10.1016\/j.yebeh.2022.108988_b0130","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/epi.14439","article-title":"Generic antiepileptic drugs-Safe or harmful in patients with epilepsy?","volume":"59","author":"Holtkamp","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108988_b0135","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1111\/j.1528-1167.2011.03130.x","article-title":"Clinical and pharmacy utilization outcomes with brand to generic antiepileptic switches in patients with epilepsy","volume":"52","author":"Erickson","year":"2011","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.yebeh.2022.108988_b0140","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s40261-015-0351-1","article-title":"Safety of Overnight Switch from Brand-Name to Generic Levetiracetam","volume":"36","author":"Vari","year":"2016","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.yebeh.2022.108988_b0145","unstructured":"H\u00e4ussler B, H\u00f6er A. Arzneimittel-Atlas 2018: Medizinisch Wissenschaftliche Verlagsgesellschaft; 2018."},{"key":"10.1016\/j.yebeh.2022.108988_b0150","unstructured":"H\u00f6er A, Maag L. Nichtverf\u00fcgbarkeit von rabattierten Arzneimitteln. In: IGES Institut Berlin; 2019."},{"key":"10.1016\/j.yebeh.2022.108988_b0155","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s42466-022-00209-5","article-title":"Impact of COVID-19 pandemic on physical and mental health status and care of adults with epilepsy in Germany","volume":"4","author":"K\u00f6rbel","year":"2022","journal-title":"Neurol Res Pract"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505022004371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505022004371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:51:29Z","timestamp":1761504689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505022004371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":31,"alternative-id":["S1525505022004371"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2022.108988","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Supply problems of antiseizure medication are common among epilepsy patients in Germany","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2022.108988","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108988"}}